Intersect ENT Stock (NASDAQ: XENT) (down 33% - so far today after poor earnings)

XENT has dropped by 200 million in market cap in 1 day from 590 million to 390 million. Wow wow wow

Post A Reply

Report this entire thread

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a thread a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the thread has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.

Really, smart guy, because the way I see it, everything has been spot on. Why don't you enlighten us if you are so smart? Where is the disconnect?

Reps have been frustrated for months and the recent talk of stocking shelves and quotas being too high should have given some insight into there being issues in sales. But you didn't read that part, did you?

Next step, earnings call: Analysts ask questions and push Lisa on challenges in the field and that is part of the reason the stock is down 30%. Maybe you are an executive or investor who doesn't understand that a medical device sales team is the main driver for a company's success once a product is in the field. When there are disruptions in the field, whether it be product related, sales related, whatever…they all start there. Maybe YOU should get out in the field and ride with a rep for a week to see what's really going on.

Keep investing in this dog because the growth stages are over unless major changes happen. The sad thing is, in order for growth to happen, there will have to be major SG&A reductions, which means you will lose the top reps and have to hire subpar ones who are open to making a max of 150k. Good luck with that.

The next step in that growth will be acquisitions which has clearly been a challenge for this management team. Bringing additional products to the market will take too long so distributing a product or an acquisition is the quickest possible way to get growth back.

I'd love to hear your insight and not just some insecure attack against us with nothing of substance to back it up with.

Reps were stocking shelves back in the day because of a directive from one particular individual.

post

How is the culture these days? There seems to be a ton of discontent in the threads on this board. Some people are very upset with management and then someone who sounds like a manager chime in and say something like "you suck."

Has the sales culture become that polarizing?

yes.

post

Really, smart guy, because the way I see it, everything has been spot on. Why don't you enlighten us if you are so smart? Where is the disconnect?

Reps have been frustrated for months and the recent talk of stocking shelves and quotas being too high should have given some insight into there being issues in sales. But you didn't read that part, did you?

Next step, earnings call: Analysts ask questions and push Lisa on challenges in the field and that is part of the reason the stock is down 30%. Maybe you are an executive or investor who doesn't understand that a medical device sales team is the main driver for a company's success once a product is in the field. When there are disruptions in the field, whether it be product related, sales related, whatever…they all start there. Maybe YOU should get out in the field and ride with a rep for a week to see what's really going on.

Keep investing in this dog because the growth stages are over unless major changes happen. The sad thing is, in order for growth to happen, there will have to be major SG&A reductions, which means you will lose the top reps and have to hire subpar ones who are open to making a max of 150k. Good luck with that.

The next step in that growth will be acquisitions which has clearly been a challenge for this management team. Bringing additional products to the market will take too long so distributing a product or an acquisition is the quickest possible way to get growth back.

I'd love to hear your insight and not just some insecure attack against us with nothing of substance to back it up with.

How is the culture these days? There seems to be a ton of discontent in the threads on this board. Some people are very upset with management and then someone who sounds like a manager chime in and say something like "you suck."

Has the sales culture become that polarizing?

post

circling the drain, if it goes below 10, time to eject

The growth of the past is dead and it isn't coming back with only one product to sell.

post

circling the drain, if it goes below 10, time to eject

post

New 52 week low for the stock

This stock sucks! What is going on at that company?

post

Well written. The systemic problem is that startup quotas are based off of VC ROI and not what the market can bear which is not a sustainable sales model; and, why statistically all vc-funded startups are underperforming post-IPO or acquisition. Reps get blamed for not growing the market when VC and executives placing blame without taking accountability for their mismanagement, likely based off fraud, is the real cause for lack of growth. Shorter: fraud is not a sustainable sales model.

So just to be clear, all publicly traded companies must succeed or its fraud??

Who ever you folks are step away from your online MBA and put the key board down before you hurt yourself.

Full honest disclosure, I dont work here but I am in the device world. This is some ignorant fully inexperienced commentary.

Companies fail everyday and it's not always fraud, it might be incompetence and/or other factors.

post

Really, smart guy, because the way I see it, everything has been spot on. Why don’t you enlighten us if you are so smart? Where is the disconnect?

Reps have been frustrated for months and the recent talk of stocking shelves and quotas being too high should have given some insight into there being issues in sales. But you didn’t read that part, did you?

Next step, earnings call: Analysts ask questions and push Lisa on challenges in the field and that is part of the reason the stock is down 30%. Maybe you are an executive or investor who doesn’t understand that a medical device sales team is the main driver for a company’s success once a product is in the field. When there are disruptions in the field, whether it be product related, sales related, whatever…they all start there. Maybe YOU should get out in the field and ride with a rep for a week to see what’s really going on.

Keep investing in this dog because the growth stages are over unless major changes happen. The sad thing is, in order for growth to happen, there will have to be major SG&A reductions, which means you will lose the top reps and have to hire subpar ones who are open to making a max of 150k. Good luck with that.

The next step in that growth will be acquisitions which has clearly been a challenge for this management team. Bringing additional products to the market will take too long so distributing a product or an acquisition is the quickest possible way to get growth back.

I’d love to hear your insight and not just some insecure attack against us with nothing of substance to back it up with.

Well written. The systemic problem is that startup quotas are based off of VC ROI and not what the market can bear which is not a sustainable sales model; and, why statistically all vc-funded startups are underperforming post-IPO or acquisition. Reps get blamed for not growing the market when VC and executives placing blame without taking accountability for their mismanagement, likely based off fraud, is the real cause for lack of growth. Shorter: fraud is not a sustainable sales model.

post

this board is joke with posters knowing nothing how Wall Street analysis correlates with companies.

Really, smart guy, because the way I see it, everything has been spot on. Why don't you enlighten us if you are so smart? Where is the disconnect?

Reps have been frustrated for months and the recent talk of stocking shelves and quotas being too high should have given some insight into there being issues in sales. But you didn't read that part, did you?

Next step, earnings call: Analysts ask questions and push Lisa on challenges in the field and that is part of the reason the stock is down 30%. Maybe you are an executive or investor who doesn't understand that a medical device sales team is the main driver for a company's success once a product is in the field. When there are disruptions in the field, whether it be product related, sales related, whatever…they all start there. Maybe YOU should get out in the field and ride with a rep for a week to see what's really going on.

Keep investing in this dog because the growth stages are over unless major changes happen. The sad thing is, in order for growth to happen, there will have to be major SG&A reductions, which means you will lose the top reps and have to hire subpar ones who are open to making a max of 150k. Good luck with that.

The next step in that growth will be acquisitions which has clearly been a challenge for this management team. Bringing additional products to the market will take too long so distributing a product or an acquisition is the quickest possible way to get growth back.

I'd love to hear your insight and not just some insecure attack against us with nothing of substance to back it up with.

post

Why?

Underperforming startups post-IPO are on SEC radar. If false projections to achieve the appearance of hypergrowth for an overvaluation were used, that's fraud. VCs and executives likely got their ROI at the expense of employees (who can't sustain false projections (lower salaries/layoffs)) and shareholders who likely bought stock based off of fraudulent information, both of which were set up for failure from the beginning. The SEC should be looking at any VC or executive regarding when and how much they profited vs their original investment, in relation to shareholder loss.

post

this board is joke with posters knowing nothing how Wall Street analysis correlates with companies.

post

Loading...


Load More

Report this post

The reason we ask for your email address is to ensure the reporting feature is not abused. Once you report a post a confirmation email will be sent to you requiring that you did in fact mean to do this action. This also gives us a way to get in touch with you privately to discuss your reasoning if we feel the post has been reported without merit.

Your email address will never be used for any other reason and will never be sold to email marketers.

A reason is required.